Researchers Open Phase I Clinical Trial of Cryoablation with Keytruda
Memorial Sloan Kettering Cancer Center in New York City has opened a novel clinical trial that combines the immunotherapy drug Keytruda with cryoablation for patients with unresectable malignant mesothelioma. The phase I trial opened in September and will be available at seven Memorial Sloan Kettering locations in the New York City/New Jersey area. Cryoablation, which is also known as cryotherapy or cryosurgery, is a treatment that freezes localized tumors with argon gas or liquid nitrogen. It has been used effectively with liver, kidney and prostate cancers, but its use with mesothelioma has been limited because of ...
Source: Asbestos and Mesothelioma News - October 14, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news
Is Cervical Cryosurgery Painful?
Title: Is Cervical Cryosurgery Painful?Category: Diseases and ConditionsCreated: 11/3/2020 12:00:00 AMLast Editorial Review: 11/3/2020 12:00:00 AM (Source: MedicineNet Womens Health General)
Source: MedicineNet Womens Health General - November 3, 2020 Category: OBGYN Source Type: news
Cryoablation Study for Mesothelioma Opening at UCLA
Researchers at UCLA Jonsson Comprehensive Cancer Center will soon begin studying the pre-surgery use of cryoablation as a potential early adjuvant therapy for patients with pleural mesothelioma. The pilot study will measure immune system stimulation through local tumor infiltration in hopes of extending patient survival in the future. Cryoablation, also known as cryotherapy or cryosurgery, freezes localized tumors with liquid nitrogen or argon gas. It has been proven effective in killing tumor cells with extreme cold. It is currently used on kidney, liver and prostate cancers, but its use in priming a person’s own immun...
Source: Asbestos and Mesothelioma News - July 1, 2020 Category: Environmental Health Authors: Fran Mannino Source Type: news
Cryosurgery Plus Topical Interventions for Actinic Keratosis Cryosurgery Plus Topical Interventions for Actinic Keratosis
Is a combination of cryosurgery with a topical intervention superior to cryosurgery alone for treatment of actinic keratoses?The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 6, 2019 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news
AtriCure launches CryoIce persistent AF ablation trial
AtriCure (NSDQ:ATRC) said today that it launched a new FDA investigational device exemption cleared trial of its CryoIce system exploring its use in treating persistent atrial fibrillation during concomitant open-chested cardiac surgery. The first patient in the trial has already been treated, the Mason, Ohio-based company said. The initial procedure took place at Takoma Park, Md.’s Washington Adventist Hospital. “Cryothermal energy has been a mainstay of surgical ablation for a long time. The ICE-AFIB IDE trial is the first of its kind designed to assess the safety and sustained effectiveness of cryothermal a...
Source: Mass Device - February 5, 2019 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Clinical Trials Surgical AtriCure Inc. Source Type: news
Topical solution may be less toxic option for patients with noncancerous skin growth
(George Washington University) A team of researchers at the GW School of Medicine and Health Sciences compared the toxicological impact of cryosurgery with an FDA-approved topical 40 percent hydrogen peroxide solution (A-101) for the treatment of seborrheic keratosis, in human skin equivalents derived from darker skin types. The findings were recently published in the Journal of the American Academy of Dermatology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 29, 2018 Category: International Medicine & Public Health Source Type: news
Medical News Today: What you should know about freezing warts
A look at freezing warts, a method of wart removal. Included is detail on how cryosurgery works, and what types of wart respond best to this treatment. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 28, 2017 Category: Consumer Health News Tags: Dermatology Source Type: news
First patient treated with CSA Medical ’ s AV spray catheter
CSA Medical said today that the first patient was treated using the company’s new rapid AV spray catheter for the management of persistent symptomatic esophageal cancer and associated dysplastic Barrett’s disease. The device uses a stainless steel catheter wall to cut the time needed to deliver liquid nitrogen spray to the treatment site by 50%, the company said. It was recently cleared for use with CSA Medical’s truFreeze system – a cryosurgical tool used to ablate benign and malignant lesions. Get the full story at our sister site, Drug Delivery Business News. The post First patient treated with CSA Medical̵...
Source: Mass Device - October 3, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Oncology Surgical CSA Medical Inc. Source Type: news
CSA Medical wins another FDA expansion for TruFreeze cryotherapy
Endoscopic cryo-ablation company CSA Medical said today it won expanded FDA 510(k) clearance for its TruFreeze spray cryotherapy system, now cleared for use on patients with Barrett’s esophagus with low grade dysplasia. With the clearance, the device is now approved for both low and high grade dysplasia as well as malignancies, the Boston-based company said. “Over the past few years, studies have underscored the potential risk for Barrett’s esophagus with low grade dysplasia to progress to esophageal adenocarcinoma. Intervening at this level of dysplasia has become common practice and is recognized in o...
Source: Mass Device - August 31, 2017 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Otolaryngology Ear, Nose & Throat Regulatory/Compliance CSA Medical Inc. Source Type: news
CSA Medical wins expanded FDA nod for TruFreeze system
Endoscopic cryo-ablation company CSA Medical said today it won FDA 510(k) clearance for a 3rd spray kit, the rapid AV spray kit, for its TruFreeze system. The Boston-based company’s TruFreeze system is designed as a cryosurgical tool designed for use in dermatology, gynecology, general surgery and to ablate benign and malignant lesions. The newly cleared addition is designed to shorten the time to liquid nitrogen spray by 50%, the company said. The company touted the TruFreeze device as the only ablation technology designed to ablate Barrett’s Esophagus with a high grade dysplasia or cancers as such as in the...
Source: Mass Device - July 17, 2017 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Catheters Food & Drug Administration (FDA) Regulatory/Compliance CSA Medical Inc. Source Type: news
DR ELLIE CANNON: I'm warming to cryosurgery to fix my foot
Morton's neuroma is a very painful and incapacitating condition that affects one of the nerves running between the toes. It tends to happen to women over 40 with a history of wearing high-heel shoes. (Source: the Mail online | Health)
Source: the Mail online | Health - December 10, 2016 Category: Consumer Health News Source Type: news
Cryoablation Successfully Treats Recurrent Mesothelioma
Radiologists at the UCLA Medical Center are successfully killing tumor cells with extreme cold, also known as cryoablation, in patients with recurrent pleural mesothelioma. An outpatient procedure with few complications, cryoablation freezes the localized tumors with argon gas or liquid nitrogen, allowing patients to fight the almost-inevitable cancer recurrence after surgery. Dr. Fereidoun Abtin, a UCLA radiologist who performs the procedure, told Asbestos.com he is “convinced it works well for these patients.” “The results have been impressive, a lot better than what else is out there in the literature ...
Source: Asbestos and Mesothelioma News - December 6, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: cryoablation for cancer cryoablation for mesothelioma cryosurgery for mesothelioma cryotherapy for mesothelioma freezing cancer tumors mesothelioma treatment Source Type: news
Cross Creek Animal Medical Centre Introduces Cryosurgery Option for Tampa Pets
(Source: Medical News (via PRIMEZONE))
Source: Medical News (via PRIMEZONE) - September 14, 2015 Category: Pharmaceuticals Source Type: news
Ingenol mebutate helped clear actinic keratoses
Cryosurgery followed by topical ingenol mebutate cleared extensive regions of actinic keratosis, which helped reveal residual squamous cell carcinomas, according to a report in the August issue of the Journal of Drugs in Dermatology. The findings show that ingenol mebutate can clear multiple AKs... (Source: Skin and Allergy News)
Source: Skin and Allergy News - August 21, 2015 Category: Dermatology Source Type: news
2015 Conquer Cancer Foundation of ASCO Young Investigator Award Funded by Kidney Cancer Association
Matthew Campbell, MD Chief Fellow, Hematology/Oncology Fellowship, UT MD Anderson Cancer CenterNew agents called immune check point inhibitors have been FDA approved in the treatment of metastatic melanoma and metastatic squamous cell lung cancer. These agents have shown exciting activity in bladder, kidney, and a variety of other cancers in early clinical studies and are being explored in larger studies. The first of these agents, ipilimumab, is an antibody that binds to CTLA-4, a molecule that is increased by T cells responding to a stimulus, to help shut off the immune response. When the an...
Source: Kidney Cancer Association - May 11, 2015 Category: Urology & Nephrology Source Type: news